$10.91
-1.37-11.12%
Last update: Nov 5, 10:56 AM
AbCellera Biologics Inc
ABCLNASDAQ
The average analyst price target for AbCellera Biologics is $13.18, 20.8% above the current price. Of 10 analysts, 8 rate it Buy and 2 Hold. Targets range from $4 to $30. The latest change came on Oct 12, 2026, when UBS initiated coverage of AbCellera Biologics with a Buy rating and a $18 price target.
Price Target Range — 12 Quarters
Analyst Consensus — 10 Analysts
Rating Trend — Last 9 Months
